CanSino Biologics, Inc. (CASBF)
2.95
-1.65
(-35.87%)
USD |
OTCM |
Sep 16, 16:00
CanSino Biologics Shareholders Equity (Quarterly) : 733.61M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 733.61M |
| March 31, 2026 | 713.05M |
| December 31, 2025 | 708.86M |
| September 30, 2025 | 692.76M |
| June 30, 2025 | 684.31M |
| March 31, 2025 | 675.53M |
| December 31, 2024 | 672.65M |
| September 30, 2024 | 721.69M |
| June 30, 2024 | 696.33M |
| March 31, 2024 | 706.54M |
| December 31, 2023 | 743.72M |
| September 30, 2023 | 790.06M |
| June 30, 2023 | 813.94M |
| March 31, 2023 | 962.07M |
| December 31, 2022 | 970.71M |
| September 30, 2022 | 1.018B |
| Date | Value |
|---|---|
| June 30, 2022 | 1.150B |
| March 31, 2022 | 1.267B |
| December 31, 2021 | 1.254B |
| September 30, 2021 | 1.148B |
| June 30, 2021 | 1.086B |
| March 31, 2021 | 924.66M |
| December 31, 2020 | 928.29M |
| September 30, 2020 | 923.15M |
| June 30, 2020 | 194.66M |
| March 31, 2020 | 204.68M |
| December 31, 2019 | 211.11M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| June 30, 2018 | 87.42M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.007B |
| Total Liabilities (Quarterly) | 243.38M |
| Debt to Equity Ratio | 0.1969 |
| Current Ratio | 4.391 |
| Net Debt Paydown Yield | 4.02% |